GeneReach Biotechnology Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 275.583 million compared to TWD 257.228 million a year ago. Operating income was TWD 139.430 million compared to TWD 125.409 million a year ago. Net income was TWD 109.730 million compared to TWD 84.765 million a year ago. Basic earnings per share was TWD 2.7 compared to TWD 2.09 a year ago. For the half year, total revenue was TWD 508.133 million compared to TWD 386.214 million a year ago. Operating income was TWD 257.364 million compared to TWD 149.368 million a year ago. Net income was TWD 202.779 million compared to TWD 97.997 million a year ago. Basic earnings per share was TWD 5 compared to TWD 2.41 a year ago. Diluted earnings per share was TWD 4.98 compared to TWD 2.41 a year ago.